Nano sensors has offering unprecedented precision and sensitivity in detecting and monitoring biological processes at the nanoscale. These miniature devices, typically ranging from 1 to 100 nanometers in size, exhibit unique properties that make them ideal for applications in drug development, diagnostics, and therapeutic monitoring. In the pharmaceutical industry, nano sensors play a crucial role in enhancing the understanding of cellular and molecular mechanisms, allowing for the design of more targeted and efficient drug delivery systems. These sensors can detect subtle changes in biomarkers, enabling early diagnosis of diseases and personalized treatment strategies.
Additionally, nano sensors contribute to the advancement of pharmacokinetics by providing real-time data on drug interactions within the body, optimizing dosages, and minimizing side effects. Their ability to navigate biological barriers at the molecular level opens up new possibilities for delivering drugs to specific cells or tissues. As the field of nanotechnology continues to evolve, nano sensors hold the promise of transforming the pharmaceutical landscape by providing innovative solutions for diagnosis, treatment, and monitoring of various medical conditions.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico